This paper reviews current practice guidelines for antithrombotic use in vascular surgery patients to address variations in prescribing practices and reduce bleeding risks.
Answers are grounded in this paper and cite their sources.
Guideline deviations in antithrombotic prescribing may heighten bleeding risk; leaves open optimal regimens and warrants implementation research.
Pre- or post-intervention, vascular surgical patients are expected to be on one or more antithrombotic agents. Antithrombotics have played a key role in reducing cardiovascular mortality in vascular patients. There are wide variations in the practice of prescribing antithrombotic agents in vascular services. Evidence-based current practice guidelines are often not strictly followed which puts some of these patients at increased risk of bleeding complications. This paper looks at the current practice guidelines on antithrombotics.
No takes yet. Share an insight, caveat, or question.
Gambhir et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: